We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

83 hedge funds and large institutions have $136M invested in Infinity Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

97% more capital invested

Capital invested by funds: $68.9M → $136M (+$66.9M)

51% more funds holding

Funds holding: 55 → 83 (+28)

7% less call options, than puts

Call options by funds: $1.66M | Put options by funds: $1.78M

Holders
83
Holders Change
+28
Holders Change %
+50.91%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
25
Reduced
9
Closed
9
Calls
$1.66M
Puts
$1.78M
Net Calls
-$124K
Net Calls Change
-$117K

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$21.9M
2
Millennium Management
Millennium Management
New York
+$7.81M
3
ACM
AIGH Capital Management
Maryland
+$5.51M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.05M
5
TLP
Tri Locum Partners
New York
+$4.04M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$30.2M
2
OM
Opaleye Management
Massachusetts
-$6.72M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.6M
4
BBA
Baker Bros. Advisors
New York
-$1.11M
5
EI
EAM Investors
California
-$893K
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
76
PNC Financial Services Group
Pennsylvania
$2K – – –
NSIM
77
North Star Investment Management
Illinois
$1K – – –
PCIA
78
Prime Capital Investment Advisors
Kansas
$1K +$917 +275 New
TWA
79
TCI Wealth Advisors
Arizona
$1K +$1K +300 New
SPIA
80
Steward Partners Investment Advisory
New York
$323 – – –
Walleye Capital
81
Walleye Capital
New York
$44 +$45.7K +13,700 New
OM
82
Opaleye Management
Massachusetts
– -$6.72M -3,171,800 Closed
BBA
83
Baker Bros. Advisors
New York
– -$1.11M -522,360 Closed
EI
84
EAM Investors
California
– -$893K -421,103 Closed
CC
85
Callan Capital
California
– -$155K -73,200 Closed
JP Morgan Chase
86
JP Morgan Chase
New York
– -$138K -41,225 -100%
AC
87
Athanor Capital
New York
– -$68K -32,153 Closed
Qube Research & Technologies (QRT)
88
Qube Research & Technologies (QRT)
United Kingdom
– -$62K -29,087 Closed
Group One Trading
89
Group One Trading
Illinois
– -$90.6K -27,156 Closed
AGM
90
Alpine Global Management
New York
– -$52K -24,575 Closed
BNP Paribas Financial Markets
91
BNP Paribas Financial Markets
France
– -$2 -1 Closed
1 2 3
4

INFI Hedge Fund Activity: Q1 2021 in Review

83 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q1 2021, worth a combined $136M — up 97% from $68.9M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new INFI positions and 9 closed out — a net gain of 29 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $21.9M. The largest seller was BVF Inc, cutting an estimated $30.2M.

  • 83 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q1 2021, up from 55 in Q4 2020.
  • Funds reported $136M of Infinity Pharmaceuticals, Inc. stock for Q1 2021, up 97% quarter-over-quarter.
  • 38 funds opened new Infinity Pharmaceuticals, Inc. positions in Q1 2021 and 9 closed out, a net change of +29 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q1 2021 was Consonance Capital Management, an estimated $21.9M added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q1 2021 was BVF Inc, an estimated $30.2M sold.

Based on aggregated 13F filings for Q1 2021.